Detalhe da pesquisa
1.
PD-L1 expression in vulvar cancer: a systematic review and meta-analysis.
Histopathology
; 84(5): 742-752, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38084642
2.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Int J Gynecol Cancer
; 34(4): 550-558, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129136
3.
Clinical experiences with online adaptive radiotherapy of vulvar carcinoma.
Acta Oncol
; 62(10): 1230-1238, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713179
4.
Gemcitabine for recurrent ovarian cancer - a systematic review and meta-analysis.
Gynecol Oncol
; 155(3): 530-537, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31604664
5.
Treatment and outcomes of a Danish ovarian cancer population.
Dan Med J
; 67(1)2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31908253
6.
Niraparib Maintenance Treatment Improves Time Without Symptoms or Toxicity (TWiST) Versus Routine Surveillance in Recurrent Ovarian Cancer: A TWiST Analysis of the ENGOT-OV16/NOVA Trial.
J Clin Oncol
; 37(34): 3183-3191, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518175
7.
Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer.
Int J Radiat Oncol Biol Phys
; 65(5): 1375-80, 2006 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16750314